Applied Pharmaceutical Analysis 2020 is Going Virtual!

October 12 - 16, 2020 Main Conference

Short Course - Monday, Oct. 19 - Tuesday, Oct. 20, 2020


APA 2020 Plenary Speakers

Richard Yost APA2020   

Professor Richard A. Yost, PhD

Colonel Allen R. and Margaret G. Crow Professor, Department of Chemistry, University of Florida

The Triple Quadrupole: Innovation, Serendipity and Persistence

Mark Rose APA2020  

Mark Rose, PhD

Director of Drug Metabolism and Pharmacokinetics, CHDI Foundation

The Role of Non-Profits in Drug Discovery and Development

rigoberto hernandez  

Professor Rigoberto Hernandez, PhD

Gompf Family Professor of Chemistry, Department of Chemistry, Johns Hopkins University

Value of Diversity, Inclusion and Equity in the Sciences

Jack Uetrecht APA2020  

Professor Jack Uetrecht, MD, PhD

Professor of Pharmacy and Medicine, Canada Research Chair in Adverse Drug Reactions, University of Toronto

Predicting the Unpredictable: How the Innate Immune Response to Drugs Predicts Risk

APA 2020 Invited Speakers

Jim Gllick APA2020

Jim Glick, PhD, Section Head, Translational and Investigational Labs, PK Sciences, Novartis

Immunogenecity Data and the Regulatory Landscape: Bioanalytical Lessons Learned from a Recent Biological Licensing Application Approval

  Jaya Goyal APA2020

Jaya Goyal, PhD, Vice President, Bioanalytical, Pharmacology, and Biomarker Development, Wave Life Sciences

Title TBA

Chongwoo Yu 

Chongwoo Yu, PhD, Master Clinical Pharmacology Reviewer, DCEP, Office of Clinical Pharmacology, OTS/CDER/OMPT/FDA

Importance of Bioanalysis in Drug Development

  Sean Kim APA2020

Sean Kim, PhD, Head, DMPK and Clinical Pharmacology, Blueprint Medicines

Title TBA

Timothy Mack APA2020

Timothy Mack, PhD, Senior Principal Scientist, Celgene

Title TBA

  Min Meng Denali 

Min Meng, Deputy CEO at Chongqing Denali Medpharma, Co. Ltd

Title TBA

 Chandra Prakash APA

Chandra Prakash, PhD, Senior Research Fellow, Agios Pharmaceuticals

Title TBA


Andrew Rowland APA2020

Andrew Rowland, PhD, Associate Professor, Flinders Univeristy and Beat Cancer Research Fellow, Cancer Counsil SA

Exosome Markers for Drug Metabolism Pathways


Bonnie Rup, PhD, Biopharmaceutical Development Expert; Bioanalysis, Immunogenicity, Regulatory, Bonnie Rup Consulting LLC

Title TBA

  Jim Shen APA 2020

Jim Shen, PhD, Director, Bioanalytical Science, Technical Outsourcing Management Lead, Bristol-Myers Squibb

Title TBA


Sekhar Surapaneni, PhD, Vice President, Nonclinical Disposition Assessment, Bristol-Myers Squibb

Challenges with Ozanimod Approval


Carmin Syznal, MBA, Scientist II / TA Liaison Neuroscience & Immunology -DMPK Group, AbbVie

Title TBA


 Kevin Johnson

Kevin Johnson, PhD, Scientist, Genentech

Distinct Species Differences for Aldehyde Oxidase Metabolism and Observed Kinetic Isotope Effects in In Vitro and In Vivo

  Tu Yian APA2020 

Yu Tian, PhD, Director, Drug Metabolism and Pharmacokinetics, AbbVie

Microbiome Mediated Pro-Drug Metabolism and Application in Gut- Restricted Drug Design

unadkat jashvanat APA

Jashvant (Jash) D. Unadkat, PhD, Milo Gibaldi Endowed Professor, Department of Pharmaceutics, School of Pharmacy, University of Washington

Complex DDI and Transporter/Metabolism Interplay: Insights from Extended CL Model


Dr. Tee Zhang cropped


Tianyi Zhang, PhD, Executive Vice President of Frontage Laboratories Inc., and General Manager of Frontage China

Title TBA


Huiyu Zhou, PhD, Director, BioAnalytical Research & Development, Celgene

Title TBA


Joleen T. White, PhD, Bioassay Development Lead at Bill and Melinda Gates Medical Research Institute

Practicing Immunogenicity Risk Assessment on Published PEGylated and Multi-specific Biotherapeutics

Zhang Guodong

Guodong Zhang, PhD, Group Head & Associate Director at Alnylam Pharmaceuticals

Bioanalytical Strategies for RNAi Therapeutic Development

   Edit Tarcsa Edit Tarcsa, PhD, Director, Research Fellow DMPK-BA, AbbVie Bioresearch Center

AbbVie Efforts to Combat COVID19 

Sessions for APA 2020 Workshops 

Regulated Bioanalysis

Regulatory Bioanalysis

When Bioanalytical Data were Critical to a Drug Product Submission or Approval

Regulatory/Immunogenicity Risk Assessments and Integrated Summary of Immunogenicity

Cell and Gene Therapy Bioanalysis in Regulated Environment

Chinese Bioanalytical Space/Regulatory Environment

Discovery Bioanalysis and New Technologies

New Technology and Platforms for Discovery Bioanalysis


Gene and Cell Therapy


Mechanistic ADME

Current and Emerging Topics in Transporter and CYP Mediated Drug-Drug Interactions

Unusual Approaches to ADME Studies

Metabolism and Toxicology - Predictive Approaches

ADME Challenges in Drug Approval - Case Studies

Combined Workshop

New Analytical Techniques - Biomarkers, Liquid Biopsy, Imaging

Exosomes (EV) and Biomarkers



Click to Download 2019 APA Program Guide

 Join our Linkedin Group:


Regulated Bioanalysis


Mechanistic ADME


Click here to register for the APA 2020 conference online.

APA 2020 will take place on-line, October 11-16th, 2020


The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3


Sign Up Today!

Privacy Policy